Osimertinib Overcomes Alectinib Resistance Caused by Amphiregulin in a Leptomeningeal Carcinomatosis Model of ALK-Rearranged Lung Cancer
Authors:
Open Access
- 1 May 2020
- journal article
- research article
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 15 (5) , 752-765
Abstract
No abstract availableKeywords
Funding Information
- Pfizer Japan
- Ono Pharmaceutical
- Cancer Research Institute
- Chugai Pharmaceutical
- Bristol-Myers Squibb
- Merck Sharp and Dohme K.K.
- AstraZeneca
- Eli Lilly Japan
- Astellas Pharma
- Taiho Pharmaceutical
- Teijin Pharma
- Boehringer Ingelheim
- Japan Society for the Promotion of Science (16H05308)
- Takeda Pharmaceutical Company
- Daiichi Sankyo Company
- Novartis Pharma
- Kanazawa Medical University
- Japan Agency for Medical Research and Development (16cm0106513h0001)
- Cancer Research Institute, Kanazawa University
- Roche
- Kanazawa University (160304ZZH2190202)
- Novartis
This publication has 41 references indexed in Scilit:
- Activation of HER Family Signaling as a Mechanism of Acquired Resistance to ALK Inhibitors in EML4-ALK–Positive Non–Small Cell Lung CancerClinical Cancer Research, 2012
- Histone Deacetylases Activate Hepatocyte Growth Factor Signaling by Repressing MicroRNA-449 in Hepatocellular Carcinoma CellsGastroenterology, 2012
- Cerebrospinal fluid concentration of gefitinib and erlotinib in patients with non-small cell lung cancerCancer Chemotherapy and Pharmacology, 2012
- Paracrine Receptor Activation by Microenvironment Triggers Bypass Survival Signals and ALK Inhibitor Resistance in EML4-ALK Lung Cancer CellsClinical Cancer Research, 2012
- MicroRNA-449 and MicroRNA-34b/c Function Redundantly in Murine Testes by Targeting E2F Transcription Factor-Retinoblastoma Protein (E2F-pRb) PathwayJournal of Biological Chemistry, 2012
- CH5424802, a Selective ALK Inhibitor Capable of Blocking the Resistant Gatekeeper MutantCancer Cell, 2011
- Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALKJournal of Clinical Oncology, 2009
- Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancerNature, 2007
- Gefitinib in Patients with Brain Metastases from Non–Small-Cell Lung Cancer: Review of 15 Clinical CasesClinical Lung Cancer, 2004
- Incidence Proportions of Brain Metastases in Patients Diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance SystemJournal of Clinical Oncology, 2004